UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

The Effect of a Meal on Brain Activation in Reward Pathways

Completed

Conditions: Brain Response to Visual Food Cues

First Posted Date: 2012-06-28

Last Posted Date: 2013-07-04

Lead Sponsor: University of Washington

Target Recruit Count: 24

Registration Number: NCT01631045

Locations: 🇺🇸
University of Washington Medical Center, Seattle, Washington, United States

Trauma Survivors Outcomes and Support Study IV

Not Applicable

Completed

Conditions: Depression
Suicide
Alcohol Use
Drug Use
Traumatic Brain Injury
Posttraumatic Stress Disorder

Interventions: Behavioral: Stepped Care Management

First Posted Date: 2012-06-21

Last Posted Date: 2017-12-13

Lead Sponsor: University of Washington

Target Recruit Count: 121

Registration Number: NCT01625416

Locations: 🇺🇸
Harborview Medical Center, Seattle, Washington, United States

The Men's Domestic Abuse Check-Up Engages Adult Men Concerned About Their Abusive Behavior and Alcohol or Drug Use

Phase 1

Completed

Conditions: Domestic Violence
Substance Abuse

Interventions: Behavioral: Motivational Enhancement Therapy
Behavioral: Educational information

First Posted Date: 2012-06-18

Last Posted Date: 2012-06-18

Lead Sponsor: University of Washington

Target Recruit Count: 140

Registration Number: NCT01621334

Locations: 🇺🇸
Innovative Programs Research Group, School of Social Work, University of Washington, Seattle, Washington, United States

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer

Phase 2

Completed

Conditions: Recurrent Non-Small Cell Lung Carcinoma
Stage IV Non-Small Cell Lung Cancer

Interventions: Other: Laboratory Biomarker Analysis
Drug: Paclitaxel Albumin-Stabilized Nanoparticle Formulation

First Posted Date: 2012-06-15

Last Posted Date: 2021-07-16

Lead Sponsor: University of Washington

Target Recruit Count: 26

Registration Number: NCT01620190

Locations: 🇺🇸
Providence Alaska Medical Center, Anchorage, Alaska, United States
🇺🇸
Bozeman Deaconess Hospital, Bozeman, Montana, United States
🇺🇸
Wenatchee Valley Hospital and Clinics, Wenatchee, Washington, United States

and more 9 locations

Managing Childhood Abdominal Pain

Not Applicable

Completed

Conditions: Pediatric Abdominal Pain

Interventions: Behavioral: Cognitive Behavioral Therapy & Social Learning
Behavioral: Education and Support

First Posted Date: 2012-06-15

Last Posted Date: 2021-04-27

Lead Sponsor: University of Washington

Target Recruit Count: 316

Registration Number: NCT01620606

Locations: 🇺🇸
Seattle Children's Hospital, Seattle, Washington, United States
🇺🇸
Mary Bridge Children's Hospital, Tacoma, Washington, United States
🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

Home-Based Versus Partner-Friendly Clinic Testing to Enhance Male Partner HIV-1 Testing During Pregnancy

Not Applicable

Completed

Conditions: Male Partner
HIV Counseling and Testing
Home Based
Pregnancy

Interventions: Other: HIV counseling and testing

First Posted Date: 2012-06-15

Last Posted Date: 2013-08-28

Lead Sponsor: University of Washington

Target Recruit Count: 488

Registration Number: NCT01620073

Locations: 🇰🇪
Ahero Sub-District Hospital, Kisumu, Nyanza, Kenya
🇰🇪
Ahero Sub-District Hospital, Nyando, Kenya, Kisumu, Nyanza, Kenya

Assisted Partner Notification to Augment HIV Treatment and Prevention in Kenya

Not Applicable

Completed

Conditions: HIV

Interventions: Other: Assisted-partner notification services

First Posted Date: 2012-06-11

Last Posted Date: 2017-04-10

Lead Sponsor: University of Washington

Target Recruit Count: 2424

Registration Number: NCT01616420

Locations: 🇰🇪
Kombewa VCT, Kisumu, Kenya
🇰🇪
Kiambu Hospital VCT, Kiambu, Kenya
🇰🇪
Joo Trh Vct, Kisumu, Kenya

and more 15 locations

Eribulin Mesylate in Treating Patients With Recurrent or Metastatic Salivary Gland Cancer

Phase 2

Completed

Conditions: Stage IVC Salivary Gland Cancer
Stage IVA Salivary Gland Cancer
Stage IVB Salivary Gland Cancer
Recurrent Salivary Gland Cancer

Interventions: Drug: eribulin mesylate

First Posted Date: 2012-06-07

Last Posted Date: 2018-09-28

Lead Sponsor: University of Washington

Target Recruit Count: 29

Registration Number: NCT01613768

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Combined Behavioral and Analgesic Trial for Fibromyalgia

Phase 3

Completed

Conditions: Fibromyalgia

Interventions: Drug: Tramadol
Drug: Placebo
Behavioral: Cognitive Behavior Therapy for FM
Behavioral: Health Education

First Posted Date: 2012-05-15

Last Posted Date: 2019-06-26

Lead Sponsor: University of Washington

Target Recruit Count: 134

Registration Number: NCT01598753

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States
🇺🇸
University of Washington, Seattle, Washington, United States

Contingency Management of Alcohol Abuse in the Severely Mentally ILL

Not Applicable

Completed

Conditions: Schizophrenia
Alcohol Abuse
Bipolar Disorder
Major Depressive Disorder

Interventions: Behavioral: Contingency Management

First Posted Date: 2012-03-30

Last Posted Date: 2017-02-23

Lead Sponsor: University of Washington

Target Recruit Count: 123

Registration Number: NCT01567943

Locations: 🇺🇸
Harborview Medical Center, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy